原发性肺腺癌及其外科疗效（附115例报告）

１９８３年６月至１９９１年１２月，手术治疗原发性肺腺癌１１５例，占同期肺癌手术２７．３％。术后１、３、５年生存率分别为６７．０％、３５．４％、２１．８％，无手术死亡。本病发生率日趋上升，误诊率高达６７．８％；根治性手术是重要治疗手段，但不能控制潜在性微转移灶。作者就其独特临床特点、影响疗效因素、Ｎ_２淋巴结清除以及全身综合治疗等有关问题进行讨论。

Primary Pulmonary Adenocarcinoma and Results of Surgical Treatment.A Report of 115 Cases

From June 1983 to October 1991,115 patients with primary pulmonary adenocarcinoma were surgically treated in our unit. This series comprised 27.3%of the total number of lung cancer patients operated on during the same period of time.In follow-up period,the 1,3,5-year survival rates showed 67.0%,35.4%and 21.8%respectively. There was no operative mortality.The analysis demonstrated a tendency of gradual increase in the incidence of pulmonary adenocarcioma. The rate of misdiagnosis of this disease was 67.8%. Radical surgical therapy is the main procedure of choice but it can not control the latent micro-metastatic foci.The clinical characteristics of pulmonary adenocarcinoma,factors influencing the effectiveness of surgical treatment,resection including N2 lymph nodes and comprehensive adjuvant general therapy were emphatically discussed.